INMD

Value Q4, 25 TTM Total revenue — — Gross profit — — Operating expenses — — Selling/general/admin expenses — — Research & development — — Operating income — — Non-Operating Income, Total — — Interest expense, net of interest capitalized — — Non-Operating Income, excl. Interest Expenses — — Unusual income/expense — — Pretax income — — Equity in earnings — — Taxes 25.38 M 94.81 M Non-controlling/minority interest — — After tax other income/expense — — Net income before discontinued operations -25.38 M -94.81 M Discontinued operations — — Net income -25.38 M -94.81 M Dilution adjustment — — Preferred dividends — — Diluted net income available to common stockholders -25.38 M -94.81 M Basic earnings per share (Basic EPS) — — Diluted earnings per share (Diluted EPS) -0.39 -1.18 Average basic shares outstanding 64.63 M — Diluted shares outstanding 65.44 M — EBITDA — — EBIT — — Cost of revenue — — Other cost of goods sold — — Depreciation & amortization (cash flow) — —